Literature DB >> 6277716

Cyclic AMP: a potent inhibitor of DNA synthesis in cultured arterial endothelial and smooth muscle cells.

R W Stout.   

Abstract

The effect of dibutyryl cyclic AMP on DNA synthesis was studied in cultured human umbilical endothelial cells and rat aortic smooth muscle cells. Dibutyryl cyclic AMP (2 X 10(-4) mol/l) inhibited DNA synthesis in both arterial cell types when they were grown in medium supplemented with whole serum or with platelet poor serum, but had no effect in the absence of serum. An effect was seen one hour after the addition of the nucleotide, and the threshold concentration was between 2 X 10(-6) and 2 X 10(-5) mol/l. These results may have relevance to the interaction of platelets and insulin with the arterial wall in the development of atherosclerosis in diabetes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277716     DOI: 10.1007/bf00253870

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  29 in total

1.  Relative insensitivity to glucagon of sterol synthesis in cultured rat aortic smooth muscle cells. Effect of dibutyryl cyclic AMP.

Authors:  R W Stout
Journal:  Diabetologia       Date:  1978-10       Impact factor: 10.122

Review 2.  Culture of vascular endothelium.

Authors:  M A Gimbrone
Journal:  Prog Hemost Thromb       Date:  1976

Review 3.  Regulation of blood platelet function by cyclic nucleotides.

Authors:  R J Haslam; M M Davidson; T Davies; J A Lynham; M D McClenaghan
Journal:  Adv Cyclic Nucleotide Res       Date:  1978

4.  Lipoprotein uptake and metabolism by rat aortic smooth muscle cells in tissue culture.

Authors:  E L Bierman; O Stein; Y Stein
Journal:  Circ Res       Date:  1974-07       Impact factor: 17.367

5.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

6.  Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis.

Authors:  R Ross; J A Glomset
Journal:  Science       Date:  1973-06-29       Impact factor: 47.728

7.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

8.  Control of DNA synthesis in cultured vascular endothelial and smooth muscle cells--response to serum, platelet-deficient serum, lipid-free serum, insulin and oestrogens.

Authors:  H Taggart; R W Stout
Journal:  Atherosclerosis       Date:  1980-12       Impact factor: 5.162

9.  Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate.

Authors:  R B Rutherford; R Ross
Journal:  J Cell Biol       Date:  1976-04       Impact factor: 10.539

10.  Human vascular endothelial cells in culture. Growth and DNA synthesis.

Authors:  M A Gimbrone; R S Cotran; J Folkman
Journal:  J Cell Biol       Date:  1974-03       Impact factor: 10.539

View more
  4 in total

1.  Intimal hyperplasia in human uterine arteries accompanied by impaired synergism between prostaglandin I2 and nitric oxide.

Authors:  S Obayashi; T Aso; J Sato; H Hamasaki; H Azuma
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Human dermal microvascular endothelial cells: an improved method for tissue culture and a description of some singular properties in culture.

Authors:  R M Marks; M Czerniecki; R Penny
Journal:  In Vitro Cell Dev Biol       Date:  1985-11

3.  Glucose inhibits replication of cultured human endothelial cells.

Authors:  R W Stout
Journal:  Diabetologia       Date:  1982-11       Impact factor: 10.122

4.  Cyclic AMP stimulates the synthesis and function of the low-density lipoprotein receptor in human vascular smooth-muscle cells and fibroblasts.

Authors:  B Middleton; A Middleton
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.